However, pioglitazone’s effects on tau pathology are mixed: it does not affect tau phosphorylation in P301S mice [117] but decreases tau hyperphosphorylation in 3xTg-AD animals [116]. This evidence concerns the gene MAPT and Alzheimer disease.